1-(BENZYLOXY)-4-BROMO-2-(TERT-BUTYL)-5-METHYLBENZENE

Catalog No.: 
ACMIRY537
CAS No.: 
2088368-92-5
Molecular Formula: 
C18H21BrO
Molecular Weight: 
333.27
1-(BENZYLOXY)-4-BROMO-2-(TERT-BUTYL)-5-METHYLBENZENE structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$271.00InquiryInquiry
1g95%$684.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(BENZYLOXY)-4-BROMO-2-(TERT-BUTYL)-5-METHYLBENZENE
IUPAC Name1-(benzyloxy)-4-bromo-2-(tert-butyl)-5-methylbenzene
Molecular FormulaC18H21BrO
Molecular Weight333.27
SMILESCC1=C(C=C(C(OCC2=CC=CC=C2)=C1)C(C)(C)C)Br
InChI KeyLRNAEZJQOIYQLM-UHFFFAOYSA-N
Synonym1-(Benzyloxy)-4-bromo-2-(tert-butyl)-5-methylbenzene;Benzene, 1-bromo-5-(1,1-dimethylethyl)-2-methyl-4-(phenylmethoxy)-
CAS No.2088368-92-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACMIRY537 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMIRY537 route product structure diagram
    ACMIRY5372088368-92-5
Inquiry

2. ACMIRY537 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMIRY537 route product structure diagram
    ACMIRY5372088368-92-5
Inquiry

3. ACMIRY537 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMIRY537 route product structure diagram
    ACMIRY5372088368-92-5
Inquiry

Comments (0)